HOMRE Ltd (NSE: HOM), ISIN INE982C01033 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HOM last traded at ₹2.21 (+1.84%), with a 52-week range of ₹0.61 to ₹3.47 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 67.45%, FIIs 0.23%, DIIs 0.10%, mutual funds 0.10%.
EquiSense Score (ECS): 24/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.